← Browse by Condition
Medical Condition
clostridioides difficile infection
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT04305769 Phase 2
Recruiting
Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)
Enrollment
260 pts
Location
United States
Sponsor
University of Virginia
NCT07285213 Phase 2
Recruiting
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
Enrollment
230 pts
Location
United States, Austr...
Sponsor
AstraZeneca